Overview

Covalon Technologies Ltd. is a researcher, developer, manufacturer, and marketer of patent-protected medical products that improve patient outcomes and save lives in the areas of advanced wound care, infection management and surgical procedures. Our head office and laboratories are located in Mississauga, Ontario, Canada. Covalon leverages its patented medical technology platforms and expertise in two ways: (i) we develop products that we sell under Covalon’s name; and, (ii) we develop and commercialize medical products for other medical companies under development and license contracts.  The Company is listed on the TSX Venture Exchange, having the symbol COV and trades on the OTQX Market under the symbol CVALF.  Covalon is incorporated under the laws of Ontario.

Stock Info
TSXVCOV
Press Releases
Mar 1, 2021

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced its first quarter fiscal 2021 results. "Our first...

Feb 26, 2021

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will release its fiscal 2021 first quarter financial results on Monday...

Jan 28, 2021

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announces its fiscal 2020 year-end results for the year ended...

View All

Email Alerts
* Required Fields
Events
Thursday, November 12, 2020
3:30pm EST
Monday, August 24, 2020
9:00am EDT
Wednesday, July 15, 2020
9:00am EDT

View All

Contact Us

For investor relations inquiries, please contact Brian Pedlar (CEO).
e-mail: bpedlar@covalon.com

 

To contact the Board of Directors to provide comments, report concerns or ask a question, please contact Abe Schwartz (Chair of the Board).
e-mail: abe@covalon.com

Contact Form